Taiji Group is based on Fuling Pharmaceutical Factory, with Fuling Pharmaceutical Factory as the core. The Taiji group with bones is composed of four companies: Sichuan Taiji Pharmaceutical Co., Ltd., Taiji Jituan Chongqing Company, Taiji Real Industry Development Company, Taiji Product Pressing Company, Taiji Packaging and Printing Company, Taiji Transportation Company and Taiji Drinking Company. In 1 9 9 6, the total production value of the whole group was 8 million. It has become a diversified and large-scale enterprise with drug production as the main task, cross-regional and cross-industry. The main products of traditional Chinese medicine produced by Jituan Company are
Taiji Tongtian Liquid, Jizhi Sugar Slurry, Jizhi Granule, Erkangning, Chantai and Huoxiang Zhengqi Liquid? And so on, and exported to Japan, Singapore, Malaysia, Xianggang and other countries and regions. Before the end of the project, Taiji Group had more than 6 kinds of Chinese and western medicines, and was developing more than 2 new products. The research and development of the second-generation products of Taiji Tongtian Liquid was listed in the "Ninth Five-Year Plan" national science and technology attack project. In 1 9 9 5, he was awarded the title of "Top Ten Outstanding Artists in Sichuan" because of his outstanding achievements and outstanding leadership. He became a pharmaceutical expert who enjoyed the subsidy from the state, and was named "Youxiu Enterprise Entrepreneur" by the State Administration of Medicine and Medicine and the State Administration of Traditional Chinese Medicine and Medicine.
GMP certification has just come to an end, followed by GSP certification. At such a critical juncture, it coincides with the national macroeconomic regulation and control, and the tight money supply. Many enterprise groups in the pharmaceutical industry have begun to feel the pressure of "lack of money" in recent years, and their production and operation are gradually stretched. In recent years, Taiji Group, which has always declared that "there will be no large-scale expansion", has begun to show its unique charm in its strategic deployment of steady growth. From January to September this year, with the overall decline of the national pharmaceutical economic situation, Taiji Group achieved sales of 5.288 billion yuan, a year-on-year increase of 2%.
The development of Taiji Group in recent years is rapid, but its expansion is steady. It fully adheres to the principle that only enterprises that are beneficial to the development of the group, can make up for the group's own shortcomings, or are conducive to the formation of new economic growth points or the adjustment of the product structure of enterprises will consider merger or acquisition. The resources acquired by Taiji are concentrated in the pharmaceutical industry. Its controllability is very strong, which not only makes the acquired enterprises embark on the road of rapid development, but more importantly, Taiji Group is formed after integration.
In p>1997, Taiji Group successfully acquired Tongjunge, which made up for its own shortcomings in the field of medicine and commerce and provided a smoother channel for Taiji products. At the same time, its advanced management ideas and business philosophy have also given Tongjunge, a century-old brand, a new life. After several years of operation, Tongjunge has become a well-known pharmaceutical commercial enterprise in China, and its sales increased from 47 million yuan in the year of acquisition to 3.5 billion yuan in 23, and it is expected to exceed 5 billion yuan in 24. Tongjunge chain pharmacies will reach 5, this year, and its subordinate pharmaceutical logistics centers in Chongqing, Chengdu, Shanghai and other places have become an important breakthrough in the next stage of Taiji Group's development. Among them, Chengdu Western Medicine will complete sales of 1.5 billion yuan this year, and Chongqing Nan 'an Tongjunge Wholesale Company will achieve sales of 1 billion yuan. The regional pharmaceutical logistics centers such as Luzhou, Mianyang, Deyang, Zigong and Yongchuan, which have been put into operation, will have sales of more than 1 million yuan next year; At the same time, the company is actively building regional logistics centers in Beijing, Shanghai, Guangzhou and Anhui Taihe to seize the national pharmaceutical market. In 22, Taiji set up a factory in Macao, striving to make Macao a test site for the group's unitary and global development and a bridgehead for Taiji to enter the international market.
In p>22, Taiji Group completed the acquisition of Southwest Pharmaceutical, which realized the strategic concept of Taiji combining Chinese and Western medicine, and provided an important position for Taiji to strive for international cooperation in the next stage, laying the foundation for comprehensive cooperation between Taiji Group and large international pharmaceutical enterprises. After entering the Southwest Pharmaceutical Industry, Taiji Group carried out a series of internal resource integration, which ended the low-speed development history of Southwest Pharmaceutical Industry for nearly 1 years in one fell swoop, with an increase of 25% in 23 and an annual sales of nearly 5 million yuan.
the word "Tai Chi" is about balance. In order to make the whole Tai Chi develop in a balanced way and form a comprehensive enterprise integrating science, industry and trade, Tai Chi has integrated several very powerful medical research institutions in China, such as Chongqing Institute of Traditional Chinese Medicine and Taiji Medical Research Institute, and has made a lot of reserves for the development of new products, and new products are constantly on the market.
Bai Lixi, chairman of Taiji Group, summarized the post-acquisition integration work into two points: first, the most important point is to change the concept. Enterprises should keenly capture the rapid changes in market demand and guide all their business activities with market demand.
secondly, we should pay attention to marketing. "Marketing is an important means to deal with the current domestic pharmaceutical market. Many enterprises, such as Southwest Pharmaceutical, have good product resources before the acquisition, but their sales are not good. After introducing good marketing concepts, this situation has been quickly improved. " At the beginning of June this year, Taiji Group announced that it had formed a sales alliance with two giants, Shanghai Leiyunshang and Guangzhou Pharmaceutical. 3 directly operated pharmacies under Taiji have officially put up the signboard of "sales alliance pharmacies", and set up sales and display counters for the products of the allied enterprises in the stores to share business networks and information with each other.
Generally speaking, the expansion speed of Taiji Group is steady and professional. They are integrating while expanding, aiming at fully integrating the acquired enterprises with the original resources, giving full play to their respective advantages, and achieving the goal that 1+1 is greater than 2. In the past two years, Taiji has stopped the pace of expansion, engaged in integration wholeheartedly, and pursued "high technology, high efficiency and high benefit", which has created the most perfect pharmaceutical industry chain in China.
Bai Lixi said that expansion is a double-edged sword. In the process of enterprise expansion, we should clearly understand the position and development stage of the enterprise, clearly evaluate our own strength, grasp the market rules in an all-round way, and work out a unique model suitable for our own development.
With GMP and GSP certification coming one after another, as well as the country's tight monetary policy and unfavorable capital environment, Taiji Group's operation in all aspects is quite good and is developing rapidly on a benign development track. "TAIJI" has become a well-known trademark in China; In the first half of the year, Taiji Group entered the "Top 5 Chinese Enterprises" (ranked 292nd), which proved Taiji's past best and strengthened its confidence in its future.
As one of the "Top 5 Chinese Enterprises", Taiji Group currently has assets of 16 billion yuan; There are three listed companies: Taiji Group-6129 Tongjunge-591 Southwest Pharmaceutical-6666; Has more than 3, large pharmacies; 13, employees, 11 pharmaceutical factories and 16 pharmaceutical commercial companies.
However, Bai Lixi said that although Taiji Group is among the top 5 Chinese enterprises at present, there is still a certain gap with Shanghai Pharmaceutical Group and Guangzhou Pharmaceutical Group, which are in the forefront of the same industry. But Taiji is already learning from them and cooperating with them. The strategic alliance agreement signed last year is the first step of their cooperation. They will jointly promote the development of medicine in the motherland and enhance the competitiveness of local pharmaceutical enterprises and foreign pharmaceutical enterprises. Bai Lixi also said that Taiji Group's achievements today are due to its good products, good team and good system. Tai Chi will take the health of the broad masses of people as its responsibility, constantly explore and innovate, and inject new vitality into the development of medical economy in China.
In the face of GMP and GSP, the tight monetary policy showed its great influence. At this time, the prudent strategy of Taiji Group began to work. Sufficient funds have been prepared for the certification of the company. So far, all the production and operation enterprises under Taiji Group have passed GMP and GSP certification of the State Food and Drug Administration.
As early as 22, after completing the acquisition of Southwest Pharmaceutical, Bai Lixi publicly stated that Taiji Group would not make large-scale acquisitions in recent years, but would focus on the integration of the acquired companies, focusing on "high technology, high efficiency and high benefit". This strategic decision of "rest and recuperation" really ensured that Taiji Group continued to maintain its growth momentum during the period of austerity. With the overall decline of the national pharmaceutical economy, from January to September this year, Taiji Group's sales reached 5.288 billion yuan, of which the pharmaceutical export trade reached 2 million yuan, and the export trade volume increased by 35% year-on-year. It is estimated that the annual export trade will exceed 5 million yuan. The industrial and commercial sales of the entire Taiji Group increased by 2% year-on-year, and it is not a problem to complete the sales of 7.5 billion yuan in 24. In the past year, it is completely expected to exceed 1 billion.
as everyone knows, the transformation of science and technology into productive forces will produce a qualitative leap, and Taiji Group is making a leap with advanced product research and development and advanced production technology. After GMP certification, the core competitiveness of the domestic pharmaceutical industry will be concentrated in the variety. Taiji Group formed a strong scientific research system during the integration period, which brought about the birth of a large number of new products with broad market prospects and laid a solid product foundation for the leap-forward development in the next stage.
behind the strong strength of Taiji Group, there is a powerful scientific research system formed in recent years, which consists of Chongqing Institute of Chinese Medicine, Taiji Medicine Research Institute, Taiji Postdoctoral Workstation and five R&D centers.
Among them, Chongqing Institute of Traditional Chinese Medicine is the largest professional research institution of traditional Chinese medicine in China, with more than 3, specimens of traditional Chinese medicine in the world, more than 5 mu of medicinal botanical gardens and 2, mu of cordyceps bases in Kangding and Shiqu. It is estimated that the output of cordyceps will reach 1 million in 28, which not only laid a foundation for the industrialization of traditional Chinese medicine, but also promoted the economic development in minority areas.
Taiji has also established postdoctoral workstations in cooperation with Peking University, Academy of Military Medical Sciences, China Pharmaceutical University and other 15 universities in China. At present, it has trained more than 2 doctoral students. The company's research and development centers are all over the world: there are Beijing New Product Design Center, German Medical Information Center, American Medical Information Center, Sydney Chinese Medicine Research Center, Macau Taiji Co., Ltd. and other institutions responsible for new product design and scientific and technological information collection.
For a long time, Taiji Group has introduced a number of well-known superior varieties with unique advantages in resources, technology, equipment, talents and network, and the development of new drugs has formed a benign pattern of development, research and reserve.
taiji group has more than 1 varieties of Chinese and western medicines. There are more than 3 varieties produced exclusively in China, more than 2 varieties protected by patents, more than 3 varieties protected by Chinese medicine and 6 varieties with annual sales exceeding 1 million yuan. Among them, Tylo, the world's most advanced diabetes drug with China patent, the world's first melatonin controlled-release preparation, Xinshubao, a sleep aid drug with good hypnotic effect and no side effects, has been popular in the market since its listing, one of the two slimming drugs approved by the United States in the past 3 years, the first slimming drug "Qumei" approved by SDA in China, the first domestic health food "Lycopene Capsule" for prostate and breast protection, and the domestic leading level. The "blockbuster" products, such as "You Ning", which can effectively and safely kill verruca plana and condyloma acuminata virus, will bring nearly 3 billion yuan of industrial output value to Taiji Group in the next five years, which will provide sufficient power for its sustainable development in the future. At the same time, Taiji Group will also develop from a pure Chinese patent medicine manufacturer into a product with international first-class western medicine and China traditional characteristics; A large-scale pharmaceutical industry and trade entity with high-end products and more essential medicines for ordinary people.
products are the extension of the extremely profound culture, and they are born out of Taiji people's ideal of "loyalty, unity, hard work and responsibility" to create health and happiness for human beings and improve the quality of life in an all-round way. "The way of civil and military affairs is relaxed one by one", and China's classical philosophy is used by Taiji, so Taiji can flourish in a virtuous circle.
Bai Lixi is a highly prestigious manager in Taiji Group. He believes that "the health industry is the longest-lived industry of human beings and will always be a vibrant industry". Bai Lixi said that some people can do many things in their life, but most of them can only do one thing well. Enterprises may involve many industries, but it is not easy to concentrate on making an industry the best. The goal of Taiji Group is clear: to make China's special medicine the best in the world. In order to achieve this goal, Taiji Group has a set of methods of "nourishing qi". Enterprises implement two sets of "teams" in employing people. One team is on the job, and the other team is on the job: either doing research, going to university for further study, or going abroad for inspection, and then "rotating posts" after three to five years.
Therefore, employees of Taiji Group, regardless of their positions, have a "hope" for promotion. After graduating from college, ordinary salesmen should first exercise in the industry and exercise in the market. After their abilities reach a certain level, they will hopefully be promoted to more important positions. When their abilities are released, they will have the opportunity to "nourish their spirits": further study, and further promotion. The middle and senior managers of Taiji Group have rich conditions: they have the opportunity to go to first-class universities in China or even abroad for further study with full salary, while continuing their studies and studying the market and learning technology. So far, * * * has more than 2 people studying for doctoral and master's degrees; More than 2 people went to the United States, Europe, Japan, Australia and other countries and regions for training and inspection.
tai chi is infinite and a healthy world. The goal of Taiji Group is to sell more than 7.5 billion yuan in 24, break through the 1 billion mark in 25 and exceed 15 billion yuan in 28. They are determined to welcome friends from all over the world with excellent performance and benefit the people.